P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells
about
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyExpression analysis of G Protein-Coupled Receptors in mouse macrophagesUDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulationPurinergic P2Y₁₄ receptor modulates stress-induced hematopoietic stem/progenitor cell senescenceSignalling and pharmacological properties of the P2Y receptor.The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.The properties of a mammary gland cancer stem cellTranscriptome analysis of genes regulated by cholesterol loading in two strains of mouse macrophages associates lysosome pathway and ER stress response with atherosclerosis susceptibilityHematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.Regulation of hematopoietic stem cell growth.Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptorGPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesityFrom quiescence to senescence.Activation of human eosinophils via P2 receptors: novel findings and future perspectives.The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.Toward 'SMART' stem cells.The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicityChemotactic activity of extracellular nucleotideson human immune cells.Endoplasmic reticulum/golgi nucleotide sugar transporters contribute to the cellular release of UDP-sugar signaling moleculesUDP-glucose promotes neutrophil recruitment in the lung.Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.Quantification of extracellular UDP-galactose.Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.Thrombin-promoted release of UDP-glucose from human astrocytoma cells.Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systemsWnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia.Shaping immune responses through the activation of dendritic cells' P2 receptors.Regulation of innate immunity by extracellular nucleotidesThe P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion.Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice.Extracellular UDP-glucose activates P2Y14 Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr705 phosphorylation and binding to hyaluronan synthase 2 (HAS2) promoter, stimulating hyaluronan synthesis of keratinocytes.Differential regulation of immune responses and macrophage/neuron interactions in the dorsal root ganglion in young and adult rats following nerve injury.Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury.P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.P2Y2 Nucleotide Receptor Prompts Human Cardiac Progenitor Cell Activation by Modulating Hippo Signaling.The expression of P2Y14, a purinergic G-protein coupled receptor, defines functionally distinct subpopulations in placenta-derived hematopoietic stem progenitor cells.
P2860
Q24629255-0274488D-E121-4B8E-8544-359A03708AF1Q24650905-34AEAED9-92AE-44D2-86B4-E913F6A7A586Q33615486-1DC056E1-516F-4AC3-B6FA-68F4B54B4F72Q33808171-91849903-9808-4D15-BE15-87805EFF10F7Q34033769-0A544A70-F12B-4400-B1BA-9FD6FC741557Q34141128-8B3C6E5C-28D7-43B3-8382-60B5C58DF861Q34637065-77CA87F9-08E3-4DE0-9020-7BF0703DD4A4Q34738282-05B7AA71-F64F-47E7-AC43-018A516B41C8Q35052404-22807573-1204-449B-828E-14E9D3D442A7Q35745912-7913CA6F-4560-41D9-8625-FFB906E2C05BQ35905170-BC763EF4-D1F6-41DB-A772-F7569398C4F1Q36128572-17735D21-F4B4-4A7F-A971-D2F0334AC973Q36140009-FB04E0CA-331A-4E01-86CD-81B73C555146Q36189156-A15CE6F6-6B13-4147-99B4-209FC382A42AQ36294569-C51F22BF-804A-40DE-B65C-57C3142AD2C5Q36308957-564F04FC-25A6-4DCE-9161-4791FFF5D750Q36935278-01B0C6E2-64A7-48BC-9901-2CD09419A3D9Q37018640-9A5A923C-DA1A-469C-8D7E-85B2FE91C6CEQ37052874-9DB8867E-BB74-4C68-A53C-75D5601187B1Q37061998-BE49EA50-D2EF-4964-A573-99C1D2CDC02CQ37135487-C37F033F-CECB-4820-8335-7A956C99A106Q37169570-A87DFD90-1971-491E-856C-358E5B90AFFFQ37442041-8573E13E-A128-4FA1-8E2F-32FD83D94AB1Q37462648-A10D5690-7451-4943-92A4-4FEAFCC3DF1BQ37464273-7C74099E-BE12-465A-90C5-5CD3E58AA094Q37964983-52862433-E240-412F-A3AC-42FFC0F2A870Q39504315-67C9F6FD-E448-45C7-8A8E-22A033C67140Q39865234-6E8E64DC-1A2C-4758-904D-F9FF4A70AA20Q40199167-DD1BB642-4254-44B0-A239-D87128CD079DQ40239647-54345656-DD95-4DF2-AF84-AA370A48A68DQ40730253-CCCC87A7-64EB-4ED5-A847-4FACA14AAA68Q42252932-6269ED52-B514-41F5-B716-C317A8C86CC3Q42482847-CE92C17E-E49E-4C62-B2D0-9AEF3302B2C6Q42741746-1945DBD7-B085-421F-A645-A95CEBC14C46Q42826562-B7891B4A-902F-4034-938A-77F90031B3EAQ42945808-B245F38D-2B04-487E-A202-8DDE296D97CEQ46269669-E71891A6-C563-4008-8B86-9CA87E7FB083Q47347659-8054022F-6730-4D5C-BCFB-431D6358CBFBQ47661844-A576B4F3-2BA9-4C71-8C36-ACD28A7F3084Q47958071-5937C2F3-0477-485B-B8AB-D52193822515
P2860
P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@ast
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@en
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@nl
type
label
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@ast
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@en
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@nl
prefLabel
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@ast
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@en
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@nl
P2093
P2860
P356
P1433
P1476
P2Y-like receptor, GPR105 (P2Y ...... arrow hematopoietic stem cells
@en
P2093
Andrew D Luster
Byeong-Chel Lee
Daniel A Haber
David Dombkowski
David T Scadden
Douglas P Olson
Eyal C Attar
Gregor B Adams
Ivona Olszak
Julie Hancock
P2860
P304
P356
10.1101/GAD.1071503
P407
P577
2003-07-01T00:00:00Z